Ryo Dairiki
Tsukuba, 3002635, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Discovery and characterization of stereodefined PMO-gapmers targeting tau.
Journal: Molecular therapy. Nucleic acids
Published: May 24, 2024
In vitro and in vivo functions of T cells produced in complemented thymi of chimeric mice generated by blastocyst complementation.
Journal: Scientific reports
Published: October 14, 2021
Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 13, 2020
Correction: Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication.
Journal: Oncogenesis
Published: September 13, 2019
Molecular mechanism and potential target indication of TAK-931, a novel CDC7-selective inhibitor.
Journal: Science advances
Published: September 10, 2018
Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability.
Journal: EMBO molecular medicine
Published: May 18, 2018
Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication.
Journal: Oncogenesis
Published: April 09, 2017
A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML Cells.
Journal: Molecular cancer therapeutics
Published: July 19, 2016
Amplification-free whole-genome bisulfite sequencing by post-bisulfite adaptor tagging.
Journal: Nucleic acids research
Published: June 01, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026